The 20 Best Acute Promyelocytic Leukemia Doctors Near Me in Lake Success, NY

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Goldberg is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Advanced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

"Dr. Joseph Jurcic is a Professor of Medicine at Columbia University Medical Center and the Director of the Hematologic Malignancies Section within the Division of Hematology/Oncology. He specializes in Medical Oncology and focuses on leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Based in New York, NY, Dr. Jurcic is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his M.D. from the Perelman School of Medicine at the University of Pennsylvania and completed his training at Barnes-Jewish Hospital and Memorial Sloan Kettering Cancer Center. He is board-certified in both Medical Oncology and Hematology.Dr. Jurcic's clinical expertise includes the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndromes. His research interests encompass acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy, developing novel small molecule inhibitors, and molecular monitoring of minimal residual disease. Recognized as one of New York Magazine's ""Best Doctors"" from 2014 to 2024, he has authored or co-authored over 80 articles and book chapters. He has served as the principal investigator on more than 25 clinical trials. Additionally, Dr. Jurcic lectures at national and international conferences and is the Leukemia Section Editor for The Oncologist.". Dr. Jurcic is rated as an Elite provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jurcic is board certified in Hematology and Medical Oncology. Dr. Jurcic is currently accepting new patients.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Tissue Biopsy.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Chitty is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Eytan Stein is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Stein is rated as an Elite provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Stein is currently accepting new patients.

Martin Tallman is a Hematologist practicing medicine in New York, New York. Dr. Tallman is rated as an Elite provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Acute Myeloid Leukemia (AML), Hairy Cell Leukemia (HCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dan Douer is a Hematologist practicing medicine in New York, New York. Dr. Douer is rated as an Elite provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Acute Myeloid Leukemia (AML).

Francis Arena is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Arena is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Arena is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Wayne Tam is a Pathologist and a Medical Genetics provider practicing medicine in New Hyde Park, New York. Dr. Tam is rated as an Advanced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Prolymphocytic Leukemia, and Chronic Myelogenous Leukemia (CML). Dr. Tam is board certified in American Board Of Pathology and American Board Of Pathology/Anatomic Pathology.

Avram Abramowitz is a Hematologist and an Oncologist practicing medicine in Rego Park, New York. Dr. Abramowitz is rated as an Advanced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Anemia. Dr. Abramowitz is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Advanced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Judith Paula Brody, MD, is a Board-certified hematopathologist, Professor in Anatomic and Clinical Pathology, and past Senior Director of the Division of Hematopathology in the Department of Pathology and Laboratory at NSLIJ, a member of the department since 1986. With expertise in both anatomic and clinical pathology, Dr. Brody specializes in the diagnosis of hematologic disorders from tissue samples like bone marrow. She also oversees one of the laboratories responsible for testing related to hematologic disorders. She completed her MD degree at Northwestern University Feinberg School of Medicine and pursued her residencies at the University of Virginia in Anatomic/Clinical Pathology, and at the New England Deaconess Hospital in Boston, and was a member of the hematopathology department at the University of Pittsburgh Medical Center prior to NSLIJ position. It is important to note that Dr. Brody does not see patients in a clinical capacity and kindly requests not to be contacted for appointments as a clinical hematologist. Dr. Brody is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Leukocytosis, Non-Hodgkin Lymphoma, Adult T-Cell Leukemia, and Acute Myeloid Leukemia (AML).

Daniel Budman is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Budman is rated as an Advanced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Acute Promyelocytic Leukemia, and Paget Disease of the Breast.

Dennis L. Cooper, MD, is Chief, Bone Marrow Transplantation and Professor, Medicine at Montefiore Einstein. His clinical focus centers on treating patients with multiple myeloma, hodgkin's lymphoma, non-hodgkin's lymphoma including bone marrow transplantation and CAR T cell therapy. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Amy Sharma , MD, is Co-Director, Hematology Oncology Fellowship Program and Assistant Professor, Hematology Oncology at Montefiore Einstein. Dr. Sharma maintains an active practice focusing on the treatment of sickle cell disease and classical hematology. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Myelofibrosis, Essential Thrombocythemia, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

I am a board certified hematologist and medical oncologist. I specialize in caring for patients with hematologic malignancies and specifically myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and aplastic anemia (AA). Dr. Shastri is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Adult T-Cell Leukemia, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.